At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,506 enrolled
Drug / intervention
D-dimer assay before ablation of atrial fibrillationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Etude du Dosage Des d-dimères sériques Pour le Diagnostic d'Exclusion Des Thrombi Intra-atriaux Avant Ablation Endocavitaire de Fibrillation Atriale
In Brief
A clinical study evaluating D-dimer assay before ablation of atrial fibrillation for Atrial Fibrillation. Completed, enrolled 2,506 participants across 37 sites.
Detailed Summary
The purpose of this study is to determine whether D-dimer dosage allow to exclude risk of intraatrial thrombus before performing an ablation of atrial fibrillation
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesFrance
CollaboratorsMedtronic
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 2014
Enrollment StartJul 2014
Primary CompletionJan 2016
Study CompletionMay 2016
TodayJul 2026
First PostedJul 24, 2014
Enrollment StartJul 28, 2014
Primary CompletionJan 1, 2016
Study CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 11.9 years ago
Interventions
D-dimer assay before ablation of atrial fibrillationother
Blood sample collection for D-dimers measurement